A phase II randomised controlled trial of high dose Vitamin D in localised prostate cancer cases with intermediate risk of progression (Pros-D).

  • Gurney, Howard (Primary Chief Investigator)
  • Butala, Radhika, (Chief Investigator)
  • Nair-Shalliker, Visalini (Other)
  • Smith, David (Other)
  • Gebski, Val (Other)
  • Patel, Manish (Other)
  • Frydenberg, Mark (Other)
  • Gardiner, Robert (Other)
  • Kimlin, Michael (Other)
  • Fenech, Michael (Other)
  • Gillatt, David (Other)

Project: Research

StatusActive
Effective start/end date1/03/16 → …